Form 4: Bausch Health Director Acquires Shares

Sentiment:

Insider Transaction Report


John Paulson, a Director at Bausch Health Companies Inc., acquired restricted stock units valued at $250,000.

Summary

  • John Paulson, a Director of Bausch Health Companies Inc. (BHC), acquired 45,871 common shares through restricted stock units (RSUs) on May 22, 2026.
  • These RSUs were granted with a value of $250,000 and vest on the day before the next Annual Meeting of Shareholders.
  • Following this transaction, Paulson directly beneficially owns 45,871 shares and indirectly beneficially owns 73,255,869 shares through managed funds where he is the controlling person of the investment manager, Paulson Capital Inc.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, as it represents a standard equity award to a director, indicating continued engagement and alignment with the company's performance.

Positives

  • Director John Paulson has acquired additional equity in Bausch Health Companies Inc., indicating confidence in the company.
  • The acquisition of 45,871 common shares through RSUs demonstrates a commitment to aligning director interests with shareholder value.

Risks

  • The filing does not explicitly mention any risks associated with this transaction.
  • Indirect beneficial ownership of a significant number of shares (73,255,869) through managed funds could present complex disclosure requirements and potential conflicts of interest, though not explicitly stated as a risk in this filing.

Future Outlook

The RSUs granted to John Paulson vest on the date immediately preceding the Issuer's next Annual Meeting of Shareholders, at which point they will be settled in common shares.

Industry Context

StockSavvy.ai notes that insider transactions, particularly those involving directors, are closely watched by the market as they can signal management's confidence in the company's future prospects. The acquisition of RSUs by a director at Bausch Health Companies Inc. is a common practice for aligning executive and director compensation with long-term shareholder value.

Stakeholder Impact

  • Shareholders: The acquisition of shares by a director may be viewed positively, suggesting confidence in the company's future performance and potential for share price appreciation.
  • Management and Board: The RSU award aligns director compensation with shareholder interests, promoting long-term value creation.

Next Steps

  • The RSUs will vest on the date immediately preceding Bausch Health Companies Inc.'s next Annual Meeting of Shareholders.
  • The RSUs will be settled in common shares of the Issuer upon vesting.

Key Dates

DateDescription
05/22/2026Transaction Date for acquisition of common shares via RSUs.
05/26/2026Date of signature for the Form 4 filing.

Keywords

Bausch Health Companies Inc., BHC, Form 4, SEC Filing, Insider Transaction, Restricted Stock Units, RSUs, Director, Equity Award, Beneficial Ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.